UCB agrees with US government to lower medicine costs and strengthen US manufacturing

·1 Sept
Share:PostShare

1 September 2026 - Belgium-based biopharmaceutical company UCB (EBR:UCB) announced on Monday that it has reached an an agreement with the US government that will continue to support patient access to ...

M

M2 Pharma

Original source

Read full story

Related Stories

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer